newsfilter
← Latest News
PR Newswire·

Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

This marks a significant step forward in the multi-regional partnership between Deciphera and Medison ZUG, Switzerland and TORONTO, Sept. 29, 2023 /CNW/ -- Today, Medison Pharma ("Medison"), a global pharma